These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 9003103)
1. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Merkel PA; Chang Y; Pierangeli SS; Convery K; Harris EN; Polisson RP Am J Med; 1996 Dec; 101(6):576-83. PubMed ID: 9003103 [TBL] [Abstract][Full Text] [Related]
2. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases. Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287 [TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual. Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508 [TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases. Chikazawa H; Nishiya K; Matsumori A; Hashimoto K J Clin Immunol; 2000 Jul; 20(4):279-86. PubMed ID: 10939715 [TBL] [Abstract][Full Text] [Related]
7. [Prevalence and specificity of antineutrophil cytoplasmic antibodies (ANCA) in connective tissue diseases]. Puszczewicz M; Zimmermann-Górska I; Białkowska-Puszczewicz G; Tuchocka A Pol Arch Med Wewn; 2003 Jan; 109(1):35-41. PubMed ID: 12879764 [TBL] [Abstract][Full Text] [Related]
8. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ghirardello A; Doria A; Zampieri S; Gerli R; Rapizzi E; Gambari PF Ann Rheum Dis; 2000 Dec; 59(12):975-81. PubMed ID: 11087701 [TBL] [Abstract][Full Text] [Related]
9. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
10. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865 [TBL] [Abstract][Full Text] [Related]
12. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702 [TBL] [Abstract][Full Text] [Related]
13. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Escalante A; Brey RL; Mitchell BD; Dreiner U Am J Med; 1995 Jun; 98(6):559-65. PubMed ID: 7778571 [TBL] [Abstract][Full Text] [Related]
14. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049 [TBL] [Abstract][Full Text] [Related]
15. Disease distribution of beta 2-glycoprotein I-dependent anticardiolipin antibodies in rheumatic diseases. Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y Lupus; 1995 Feb; 4 Suppl 1():S27-31. PubMed ID: 7757107 [TBL] [Abstract][Full Text] [Related]
16. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations. Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Samarkos M; Davies KA; Gordon C; Loizou S Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839 [TBL] [Abstract][Full Text] [Related]
18. Value of anticardiolipin antibodies for monitoring disease activity in systemic lupus erythematosus and other rheumatic diseases. Buttgereit F; Grünewald T; Schüler-Maué W; Burmester GR; Hiepe F Clin Rheumatol; 1997 Nov; 16(6):562-9. PubMed ID: 9456008 [TBL] [Abstract][Full Text] [Related]
19. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168 [TBL] [Abstract][Full Text] [Related]